Vance Terry 4
4 · ENANTA PHARMACEUTICALS INC · Filed Mar 8, 2024
Insider Transaction Report
Form 4
Vance Terry
Director
Transactions
- Award
Stock Option (right to buy)
2024-03-06+15,700→ 15,700 totalExercise: $15.66Exp: 2034-03-06→ Common Stock (15,700 underlying)
Footnotes (1)
- [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 6, 2024), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2025 annual meeting of stockholders.